Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3019417 | Revista Española de Cardiología Suplementos | 2012 | 4 Pages |
Abstract
The latest guidelines on the management of dyslipidemia produced by the European Society of Cardiology (ESC) emphasize that preventative treatment should be based on an assessment of the individual's total cardiovascular risk. The recommended assessment tool is the modified SCORE (Systematic Coronary Risk Evaluation) risk chart, which takes high-density lipoprotein cholesterol into account. The chart classifies asymptomatic patients according to their risk of dying from cardiovascular disease in the next 10 years: very high (>10%), high (5-10%), moderate (1-5%) or low (<1%). The use of additional complementary risk markers or risk factors (e.g. other lipid or laboratory parameters, the results of imaging techniques such as carotid ultrasonography, the coronary calcium score or the ankle-brachial index) are considered useful for refining risk assessment in intermediate-risk patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Eduardo AlegrÃa Ezquerra, Ana AlegrÃa Barrero, Eduardo AlegrÃa Barrero,